Related Experiment Videos
Cytogenetic aberrations and their prognostic impact in chondrosarcoma
Nils Mandahl1, Pelle Gustafson, Fredrik Mertens
1Department of Clinical Genetics, University Hospital, Lund, Sweden. nils.mandahl@klingen.lu.se
Genes, Chromosomes & Cancer
|January 17, 2002
Summary
Genomic aberrations in chondrosarcoma, excluding EMC, were analyzed. Loss of chromosome 13q (13q deletion) was identified as an independent prognostic factor for metastasis in bone cancer patients.
Area of Science:
- Oncology
- Genetics
- Bone Cancer Research
Background:
- Chondrosarcoma is a common primary bone malignancy with limited prognostic factors beyond tumor grade and size.
- Cytogenetic data for chondrosarcoma are scarce, particularly for specific chromosomal rearrangements, hindering prognostic understanding.
- Extraskeletal myxoid chondrosarcoma (EMC) is the only subtype with identified specific chromosomal rearrangements.
Purpose of the Study:
- To investigate genomic aberrations in 59 chondrosarcomas (excluding EMC) using chromosome banding and DNA flow cytometry.
- To correlate identified genomic aberrations with clinical outcomes, specifically metastasis-free survival.
- To identify potential prognostic markers for chondrosarcoma progression and metastasis.
Main Methods:
- Chromosome banding analysis and DNA flow cytometry were performed on 59 chondrosarcoma samples (grades 1-3, including dedifferentiated tumors).
- Genomic imbalances were identified and correlated with clinical data, including metastasis and survival.
- Univariate analysis was used to assess the association between genomic changes and metastasis-free survival.
Main Results:
- Abnormal karyotypes were found in 36 of 59 cases; no recurrent structural aberrations were identified, but a nonrandom pattern of gains and losses was observed.
- Common genomic imbalances included deletions in 1p, 4, 5q, 6q, 9p, 10p, 10q, 11p, 11q, 13q, 14q, 18p, 18q, and 22q, and gains in 7p, 12q, 19, 20p, and 21q.
- Loss of chromosome 13q (13q deletion) was the sole independent prognostic factor for metastasis, irrespective of tumor grade or size.
Conclusions:
- Genomic aberrations, particularly chromosomal losses, are common in chondrosarcoma and are associated with clinical outcome.
- Loss of 13q is a significant independent predictor of metastasis in chondrosarcoma patients.
- These findings highlight the importance of cytogenetic analysis in understanding chondrosarcoma behavior and predicting patient prognosis.